Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
CD4+CD25+ T cells play a central role in the suppression of autoimmunity and inflammation, making their in vivo expansion a highly attractive therapeutic target. By phenotyping with a novel rat CTL antigen‐4 (CTLA‐4)‐specific monoclonal antibody (mAb) and functional in vitro assays, we here first establish that rat CD4+CD25+ T cells correspond to the regulatory T cells (T reg cells) described in mice and humans: they constitutively express CTLA‐4, produce IL‐10 but not IL‐2, and are able to suppress the proliferation of costimulated CD25‐negative indicator cells. Furthermore, we show that rat T reg cells respond less well than CD25– T cells to conventional costimulation, but are readily expanded in vitro with "superagonistic" CD28‐specific mAb which are potent mitogens for all T cells without the need for TCR engagement. In vivo, functional T reg cells are preferentially expanded by CD28 stimulation over other T cell subsets, leading to a 20‐fold increase within 3 days in response to a single antibody dose. These data suggest that CD28‐driven activation of T reg cells may be highly effective in the treatment of inflammatory and autoimmune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodent models, treatment with CD28 superagonists orthologous to TGN1412 stimulated the release of anti-inflammatory cytokines and the expansion of regulatory T-cells believed to counter autoimmune responses (Rodríguez-Palmero et al., 1999;Lin and Hünig, 2003;Beyersdorf et al., 2005).”
From Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 + effector memory T‐cells (2010) · cites this paper as Lin and Hünig, 2003
In the citing paper
“injection of such 'superagonistic (SA)' mAbs (also called CD28 superagonists, CD28SA) into rats resulted in a preferential activation and expansion of a subset of CD4 T cells called regulatory T cells (Treg cells) [2]”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [2]
In the citing paper
“Rapid expansion of regulatory T cells (here defined by FACS analyses as CD4+ CD25+ cells among splenic lymphocytes) in rats after a single injection of the rat-specific CD28SA JJ316.Modified from Ref.[2].”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [2]
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & O'Garra, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011629 · Cited by 1,161
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Chambers, C. A., Kuhns, M. S., Egen, J. G., & Allison, J. P. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.565 · Cited by 998
Gorelik, L., & Flavell, R. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80170-3 · Cited by 962
Powrie, F., Carlino, J., Leach, M. W., Mauze, S., & Coffman, R. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2669 · Cited by 894
Origin of regulatory T cells with known specificity for antigen
Apostolou, I., Sarukhan, A., Klein, L., & von Boehmer, H. (2002) · Nature Immunology · doi:10.1038/ni816 · Cited by 847
Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N., & Shevach, E. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1224 · Cited by 829
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells
Piccirillo, C. A., & Shevach, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1137 · Cited by 716
Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A. M., & Adorini, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1945 · Cited by 617
Fowell, D., & Mason, D. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.627 · Cited by 436
Papiernik, M. (1998) · International Immunology · doi:10.1093/intimm/10.4.371 · Cited by 434
Sadlack, B., Löhler, J., Schorle, H., Klebb, G., Haber, H., Sickel, E., Noelle, R. J., & Horak, I. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251111 · Cited by 423
Powrie, F., & Mason, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1701 · Cited by 413
McGuirk, P., & Mills, K. H. G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02288-3 · Cited by 350
Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., & Nagaoka, I. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1066::aid-immu1066>3.0.co;2-# · Cited by 347
Stephens, L. A., & Mason, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3105 · Cited by 311
Peripheral Autoantigen Induces Regulatory T Cells that Prevent Autoimmunity
Seddon, B., & Mason, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.877 · Cited by 274
Seddon, B., & Mason, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.279 · Cited by 255
TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
Takeuchi, M., Alard, P., & Streilein, J. W. (1998) · PubMed · Cited by 220
Lühder, F., Huang, Y., Dennehy, K. M., Guntermann, C., Müller, I., Winkler, E., Kerkau, T., Ikemizu, S., Davis, S. J., Hanke, T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021024 · Cited by 193
Tacke, M., Hanke, G., Hanke, T., & Hünig, T. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270136 · Cited by 163
Self-citationTGF-β Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells
Takeuchi, M., Alard, P., & Streilein, J. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1589 · Cited by 161
Rolph, M. S., Raupach, B., Köbernick, H. H. C., Collins, H. L., Pérarnau, B., Lemonnier, F. A., & Kaufmann, S. H. E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1944::aid-immu1944>3.0.co;2-r · Cited by 84
Self-citationTacke, M., Clark, G. J., Dallman, M. J., & Hünig, T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5121 · Cited by 47
Self-citationCharacterization of rat CD80 and CD86 by molecular cloning and mAb
Maeda, K. (1997) · International Immunology · doi:10.1093/intimm/9.7.993 · Cited by 41
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Self-citationRodriguez-Palmero, M. (1999) · doi:10.1002/(sici)1521-4141(199912)29:12<3914::aid-immu3914>3.0.co;2-#
Self-citation
Research works printed but not linked: 4
- 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T · doi:10.1002/1521-4141(200106)31:6<1637::aid-immu1637>3.0.co;2-t
- 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P · DOI · Paper page
- 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M · DOI · Paper page
- 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO;2-M · doi:10.1002/1521-4141(200003)30:3<876::aid-immu876>3.0.co;2-m
Cited by
Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., & Martin, F. (2004) · European Journal of Immunology · doi:10.1002/eji.200324181 · Cited by 880
Weirather, J., Hofmann, U. D. W., Beyersdorf, N., Ramos, G. C., Vogel, B., Frey, A., Ertl, G., Kerkau, T., & Frantz, S. (2014) · Circulation Research · doi:10.1161/circresaha.115.303895 · Cited by 699
Immunostimulatory monoclonal antibodies for cancer therapy
Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D. M., & Chen, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2051 · Cited by 627
An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection
Cabrera, R., Tu, Z., Xu, Y., Firpi, R. J., Rosen, H. R., Liu, C., & Nelson, D. R. (2004) · Hepatology · doi:10.1002/hep.20454 · Cited by 562
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R., & Edinger, M. (2004) · Blood · doi:10.1182/blood-2004-01-0086 · Cited by 494
Metadata
- Authors
- Lin, C., & Hünig, T.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Hünig, Thomas
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2003-02-17
- Volume
- 33
- Issue
- 3
- Pages
- 626-638
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1992139204
- Cited by
- 184
- References
- 44
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 8 · 2014: 10 · 2013: 6 · 2012: 11
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- regulatory T cells, CD28 costimulation, CTLA-4, CD4+CD25+ T cells, Treg cell expansion, Treg suppressive function, IL-10, autoimmune disease therapy, inflammatory disease therapy, T cell activation
- MeSH terms
- Abatacept, Animals, Antigens, Differentiation, Interleukin-2, Mice, Inbred BALB C, Rats, Inbred Lew, T-Lymphocytes, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Interleukin-10, CD28 Antigens, Immunoconjugates, T-Lymphocytes, Regulatory, Mice, Rats, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.